Cargando…
332P Impact of the COVID-19 pandemic in the early-onset colorectal cancer (EOCRC)
Autores principales: | Baraibar Argota, I., Garcia Rodriguez, A., Salvà Ballabrera, F., Ros Montana, F.J., Saoudi Gonzalez, N., Comas, R., Castillo, G., Sanchis, M., Hernando Cubero, J., García-Alvarez, A., Capdevila Castillon, J., Martí, M., Landolfi, S., Espin, E., Nuciforo, P.G., Vivancos, A., Tabernero, J., Elez Fernandez, M.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472523/ http://dx.doi.org/10.1016/j.annonc.2022.07.470 |
Ejemplares similares
-
Impact of the COVID-19 pandemic in the early-onset colorectal cancer
por: Baraibar, Iosune, et al.
Publicado: (2023) -
Sex and gender perspectives in colorectal cancer
por: Baraibar, I., et al.
Publicado: (2023) -
Encorafenib plus cetuximab for the treatment of
BRAF-V600E-mutated metastatic colorectal
cancer
por: Ros, Javier, et al.
Publicado: (2022) -
Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
por: Baraibar, Iosune, et al.
Publicado: (2021) -
Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
por: Ros, Javier, et al.
Publicado: (2023)